Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Asian Shares Fall On Trump-Xi Agreement Scepticism, US Treasury Yields

Wed, 05th Dec 2018 08:44

CANBERA (Alliance News) - Asian stocks ended broadly lower on Wednesday amid concerns over trade and worrying signals of economic health after the difference between three- and five-year US Treasury yields dropped below zero.

Traders were sceptical around the Trump-Xi agreement announced over the weekend.

In China, traders paid little attention to encouraging services data. The benchmark Shanghai Composite index fell 16.15 points or 0.6% to 2,649.81 while Hong Kong's Hang Seng index tumbled 1.6% to close at 26,819.68.

The services sector in China continued to expand in November, and at an accelerated rate, the latest survey from Caixin revealed with a PMI score of 53.8. That beat expectations for 50.8, which would have been unchanged from the October reading.

Japanese shares fell after a plunge on Wall Street overnight on growth and trade concerns. The Nikkei average shed 116.72 points or 0.5% to finish at 21,919.33, while the broader Topix index closed 0.5% lower at 1,640.49.

China-focused shares ended lower, with Fanuc losing 3.4% and Rohm declining 1.5%. In the tech sector, Advantest slumped 4.6% and Tokyo Electron shed 1.8%.

Drug giant Takeda rose 1.1% after it received shareholder approval to acquire Irish pharmaceuticals firm Shire in a deal worth around USD60 billion.

On the economic front, the latest survey from Nikkei showed that the services sector in Japan continued to expand in November, albeit at a fractionally slower pace with a PMI score of 52.3, down from 52.4 in October.

Australian markets hit a two-week low before ending off their day's lows, dragged down by banks after official data showed the economy slowed more than expected in the third quarter of 2018.

Australia's GDP grew a seasonally adjusted 0.3% sequentially in the last quarter, missing expectations for an increase of 0.6% and down from 0.9% in the second quarter. On a yearly basis, GDP expanded 2.8% - again missing forecasts for 3.3% and down from 3.4% in the three months prior.

Another report from the Australian Industry Group revealed that the service sector in Australia continued to expand in November, and at a sharply faster rate.

The benchmark S&P/ASX 200 index ended down 44.70 points or 0.8% at 5,668.40 after losing 1.0% in the previous session. The broader All Ordinaries index dropped 48.40 points or 0.8% to 5,749.10

The big four banks fell between 0.7% and 1.2%. Mining heavyweights BHP Billiton and Rio Tinto rose modestly while energy majors Oil Search, Origin Energy, Beach Energy and Santos lost around 2% as oil resumed declines in Asian trade.

Rare earths miner Lynas Corp plummeted 22% after tough new conditions were announced for the company's license to operate in Malaysia.

Seoul stocks recovered some lost ground after hitting over one-week low earlier in the day. The benchmark Kospi fell over 1% before recouping some loss to end the session down 13.04 points or 0.6% at 2,101.31 on continued uncertainty over the Sino-US trade war.

New Zealand shares fell sharply as a flattening Treasury yield curve and doubts about the durability of the US-China trade war truce sparked worries about global growth.

The benchmark S&P/NZX 50 index dropped 84.23 points or 1.0% to finish at 8,781.53. Trade Me shares bucked the weak trend to end 3.1% higher after a second bidder emerged for the e-commerce leader.

Singapore's Straits Times index was down 0.6%. The country's private sector continued to expand in November, and at a faster rate, the latest survey from Nikkei showed with a PMI score of 53.8, up from 52.6 in October.

Overnight, US stocks tanked as the initial euphoria generated by a truce between the US and China over trade evaporated and an inverted yield curve in bond markets signalled an economic slowdown.

The Dow Jones Industrial Average tumbled 3.1%, the tech-heavy Nasdaq Composite plummeted 3.8% and the S&P 500 lost 3.2%.

More News
24 Aug 2018 11:54

LONDON MARKET MIDDAY: Stocks Up; Powell To Make Jackson Hole Debut

LONDON (Alliance News) - Stocks in London were marginally higher at midday on Friday ahead of a highly anticipated speech from the head of the US Federal Reserve.With US-China trade talks demoting a

Read more
24 Aug 2018 10:39

WINNERS & LOSERS SUMMARY: Shire Rises As US FDA Approves Takhzyro Drug

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 2.6%. The Irish pharmaceutical company said a

Read more
24 Aug 2018 08:38

LONDON MARKET OPEN: Stocks Mixed, Shire Rises After Drug Approval

LONDON (Alliance News) - Stock prices in London were mixed early Friday, as markets await US Federal Reserve Chair Jerome Powell's speech in Wyoming later in the day. In the large cap index rose

Read more
24 Aug 2018 08:06

FDA gives nod to Shire's TAKHZYRO treatment

(Sharecast News) - Shire announced on Friday that, following priority review, the US Food and Drug Administration (FDA) has approved the 'TAKHZYRO' (lanadelumab-flyo) injection for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients 12 years of age and older.

Read more
24 Aug 2018 07:41

LONDON MARKET PRE-OPEN: Slightly Lower Call Ahead Of Powell Speech

LONDON (Alliance News) - Stock prices in London are seen lower on Friday ahead of US Federal Reserve Chair Jerome Powell's speech later during the day, while in a quiet day for UK company news In

Read more
13 Aug 2018 10:31

WINNERS & LOSERS SUMMARY: Chemring Says Fatal Accident To Hurt Profit

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------BAE up 0.8%. a

Read more
13 Aug 2018 09:21

Shire Partner Shionogi Files New Drug Application For Intuniv In Japan

LONDON (Alliance News) - Irish drugmaker Shire PLC said on Monday its Japanese partner Shionogi & Co Ltd has submitted a new drug application for the manufacture and marketing of Intuniv in is

Read more
13 Aug 2018 07:51

Shire and Shionogi apply to expand ADHD treatment to adults

(Sharecast News) - Shire and Shionogi have applied to expand the use in Japan of co-developed drug Intuniv to treat adults for attention deficit hyperactivity disorder.

Read more
31 Jul 2018 12:51

TOP NEWS: Shire Income Up In 2nd-Quarter Ahead Of Takeover By Takeda

LONDON (Alliance News) - Irish biotechnology company Shire PLC on Tuesday posted a more than doubled pretax income in the second quarter, ahead of its upcoming takeover by Takeda Pharmaceutical Co

Read more
31 Jul 2018 12:12

Shire posts 4 pct rise in Q2 earnings ahead of sale to Takeda

LONDON, July 31 (Reuters) - Shire, the London-listed pharmaceutical group being bought by Japan's Takeda, reported a 4 percent rise in second-quarter earnings as revenue rose 5 percent to just

Read more
31 Jul 2018 12:08

Shire's quarterly sales rise on immunology demand

(Sharecast News) - Shire reported healthy sales growth in the second quarter as the biotech company pressed ahead with its acquisition by Takeda of Japan.

Read more
31 Jul 2018 08:05

UPDATE 1-Takeda posts weakest Q1 profit in three years

* Q1 operating profit Y98.9 bln vs Y195 bln a year earlier * Takeda booked gains from asset sales a year earlier (Adds details) TOKYO, July 31 (Reuters) - Japan's Takeda Co Ltd a

Read more
25 Jul 2018 07:00

RPT-ANALYSIS-Buy yen in crisis? Not this year

* Yen weakest G10 currency this month despite global turbulence * Investors doubt BOJ can reduce stimulus aggressively * Japanese purchases of foreign equities highest in nearly Bond

Read more
24 Jul 2018 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 25 July GlaxoSmithKlineHalf Year Results (at 1200 BST)Vodafone GroupTrading 26

Read more
24 Jul 2018 15:08

ANALYSIS-Buy yen in crisis? Not this year

* Yen weakest G10 currency this month despite global turbulence * Investors doubt BOJ can reduce stimulus aggressively * Japanese purchases of foreign equities highest in nearly Bond

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.